LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Jan 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-01-04

Reporting Person: May Larry Alan (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-04	Stock Options (Right to Buy)	$.52	A	200000	Acquired	2022-01-03	Common Stock, par value $0.001 per share (200000)	Direct

Footnotes

F1: On January 4, 2012 (the "Grant Date"), the Reporting Person was granted an option to purchase 200,000 shares of common stock of NeoStem, Inc. (the "Company"), subject to all of the terms and conditions of the Company's 2009 Equity Compensation Plan. This option vested as to one-third of the shares on the Grant Date, and is scheduled to vest as to one-third of the shares on each of January 4, 2013 and January 4, 2014.